This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Blood Processing Supplies And Equipment Industry

Medical II-61

Fenwal Obtains US FDA Approval for Software II-62

Terumo Concludes Acquisition of CaridianBCT II-62

BD Acquires Carmel Pharma II-63

Fenwal Enters into an Agreement with GenesisBPS II-63

Sysmex Canada and Diagnostic Services of Manitoba Enter into

Agreement II-64

Fenwal, Golden Meditech to Form JV for Selling Blood

Collection Products in China II-64

BD Acquires Accuri Cytometers II-65

BioCurex and VetRed Enter into Cancer Test Distribution Agreement II-65

Haemonetics and Consorta Enter into Agreement II-65

Stago Group Acquires Coagulation Business of Trinity Biotech II-66

Haemonetics, Quotient Biodiagnostics Group and Alba Bioscience

Enter into Agreement II-66

Sekisui Chemical to Merge Shanghai Daiichi Diagnostics and

Sekisui Trank II-67

Haemonetics and Global Med Technologies Enter into Definitive

Acquisition Agreement II-67

Pall Enters into Agreement with ASI II-67

Fenwal Gains FDA Approval for ALYX™ System with Wireless-

Enabled Data Export Capabilities II-68

Fenwal Obtains US FDA Approval for ALYX Component Collection

System II-69

RFCL Limited, Diagon Ink Agreement II-69

Guangzhou Instruments Obtains FDA Clearance for New Serum Tube II-69

Cytomedix Signs Deal to Acquire Sorin's Angel System and

activAT Kit II-69

Sekisui Chemical to Combine Chinese Medical Subsidiaries II-70

15. CORPORATE ACTIVITY IN THE RECENT PAST - A HISTORIC PERSPECTIVEBUILDER II-71BD Diagnostics Receives FDA Approval for BD Vacutainer® RapidSerum Tube II-71Aurora to Acquire HLTH's Porex Corporation II-71Sysmex Secures FDA Approval for XE-2100D AHA II-71Fenwal to Establish JV with Golden Meditech for Blood-relatedTechnologies II-72Haemonetics Takes Over SEBRA Blood Collection and ProcessingAssets II-72UK Biobank Selects RTS' Automated Systems II-73NHSBT Deploys PK7300 Automatic Blood Grouping Solution II-73Hemo Bioscience Inks Distribution Agreement with ARC for BloodGrouping Reagents II-74Haemonetics Snaps Up Neoteric Technology II-74Shandong Taibang Divests Stake in Xi'an Huitian Blood Products II-74Haemonetics Acquires Altivation Software II-74Asahi Kasei Medical to Sign Agreement with TechniKrom II-75BioE Secures 510(k) FDA Approval for PrepaCyte®-CB II-75BCT Japan to Change Name to CaridianBCT II-75Escalon Medical Acquires Biocode Hycel's Hematology Business II-76American Red Cross and CaridianBCT Enter into Agreement II-76Gambro BCT Changes Official Name to CaridianBCT II-76Terumo and Hettich Enter into Global Pact for New BloodProcessing System II-76Haemonetics Acquires Haemoscope's Hemostasis Analyzer Business II-77Rheologics Technologies Purchases Cardiodyne Electronics II-77ThermoGenesis Makes 510(k) Appeal to FDA II-77ThermoGenesis To Deliver Technology To SCP for Research II-77Haemonetics Acquires Infonale II-78ViaCell Integrates Automation into Closed Blood Processing System II-78HTL-Strefa Wins 12 Million Contract II-78Biosafe Receives US FDA 510(k) Clearance for SEPAX II-78HMD To Expand Production Capacity II-78Quotient BioResearch Acquires Alba Bioscience II-79Fresenius Kabi to Acquire Kyorin's Blood Volume ReplacementOperations II-79Haemonetics Acquires Assets of IDM II-79Baxter Divests Transfusion Therapies Business II-80Immucor's Galileo Echo Receives FDA Clearance for Marketing II-80ThermoGenesis Submits Application to US FDA for NewAutoXpress™ System II-80


5 of 22

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs